Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Breast Neoplasms 2Wounds and Injuries 1Stroke 1Stomach Neoplasms 1Spinal Cord Injuries 1Rectal Neoplasms 1Pain, Postoperative 1Muscular Atrophy 1Muscle Spasticity 1Low Anterior Resection Syndrome 1Hereditary leiomyomatosis and renal cell cancer 1Ganglion Cysts 1Esophageal Neoplasms 1Cluster Headache 1Carcinoma, Renal Cell 1Breast Diseases 1Brain Injuries 1

Interventions

Cisplatin 117Oxaliplatin 111Fluorouracil 100Capecitabine 90Docetaxel 69Leucovorin 60Irinotecan 57Paclitaxel 49S 1 (combination) 38pembrolizumab 33Trastuzumab 31Radiotherapy 25Bevacizumab 20Nivolumab 19Epirubicin 19titanium silicide 18Surgical Procedures, Operative 17Carboplatin 17Ramucirumab 15Cetuximab 15Gastrectomy 13apatinib 12Everolimus 12Gemcitabine 11Albumin-Bound Paclitaxel 10Neoadjuvant Therapy 8Folfox protocol 8Drug Therapy 8Chemotherapy, Adjuvant 8Radiation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Stomach Neoplasms × Botulinum Toxins, Type A × Clear all
NCT01822210 2018-03-09

Botulinum Toxin for Stomach Cancer Treatment

St. Olavs Hospital

Phase 2 Completed
7 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡